Symptomatic parvovirus B19 infection caused by blood component transfusion

Transfusion

Volumn 51, Issue 9, 2011, Pages 1887-1895

  Satake, Masahiro ^a   Hoshi, Yuji ^a   Taira, Rikizo ^a   Momose, Shun Ya ^a   Hino, Satoru ^a   Tadokoro, Kenji ^a  

^a Japanese Red Cross Society   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN M ANTIBODY; VIRUS DNA;

ANEMIA; ANTIBODY DETECTION; ANTIGEN DETECTION; APLASTIC ANEMIA; ARTICLE; BLOOD COMPONENT THERAPY; BLOOD DONOR; BLOOD SAFETY; BLOOD SAMPLING; BLOOD STORAGE; CONTROLLED STUDY; DNA SEQUENCE; ERYTHEMA INFECTIOSUM; HEMAGGLUTINATION TEST; HEMATOLOGIC DISEASE; HEMATOLOGIC MALIGNANCY; HUMAN; HUMAN PARVOVIRUS B19; MAJOR CLINICAL STUDY; PANCYTOPENIA; POLYMERASE CHAIN REACTION; RED CROSS; SCREENING; VIREMIA; VIRUS LOAD; VIRUS TRANSMISSION;

ADULT; BLOOD COMPONENT TRANSFUSION; FEMALE; HUMANS; MALE; MIDDLE AGED; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; POLYMERASE CHAIN REACTION;

EID: 79960354335     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2010.03047.x     Document Type: Article

References (33)

1. Young NS, Brown KE,. Parvovirus B19. N Engl J Med 2004; 350: 586-97.
2. Parsyan A, Candotti D,. Human erythrovirus B19 and blood transfusion: an update. Transfus Med 2007; 17: 263-78. (Pubitemid 47197759)
3. Heegaard ED, Brown KE,. Human parvovirus B19. Clin Microbiol Rev 2002; 15: 485-505. (Pubitemid 34761354)
4. Zaaijer HL, Koppelman MH, Farrington CP,. Parvovirus B19 viraemia in Dutch blood donors. Epidemiol Infect 2004; 132: 1161-6. (Pubitemid 39642399)
5. Vyse AJ, Andrews NJ, Hesketh LM, Pebody R,. The burden of parvovirus B19 infection in women of childbearing age in England and Wales. Epidemiol Infect 2007; 135: 1354-62. (Pubitemid 351148097)
6. Brown KE, Simmonds P,. Parvoviruses and blood transfusion. Transfusion 2007; 47: 1745-50. (Pubitemid 47438565)
7. Kurtzman G, Frickhofen N, Kimball J, Jenkins DW, Nienhuis AW, Young NS,. Pure red-cell aplasia of 10 years duration due to persistent parvovirus B19 infection and its cure with immunoglobulin therapy. N Engl J Med 1989; 321: 519-23. (Pubitemid 19203877)
8. Blümel J, Schmidt I, Effenberger W, Seitz H, Willkommen H, Brackmann HH, Löwer J, Eis-Hübinger AM,. Parvovirus B19 transmission by heat-treated clotting factor concentrates. Transfusion 2002; 42: 1473-81.
9. Kawamura M, Sawafuji M, Watanabe M, Horinouchi H, Kobayashi K,. Frequency of transmission of human parvovirus B19 infection by fibrin sealant used during thoracic surgery. Ann Thorac Surg 2002; 73: 1098-100. (Pubitemid 34275886)
10. Erdman DD, Anderson BC, Török TJ, Finkel TH, Anderson LJ,. Possible transmission of parvovirus B19 from intravenous immune globulin. J Med Virol 1997; 53: 233-6. (Pubitemid 28201831)
11. Cohen BJ, Beard S, Knowles WA, Ellis JS, Joske D, Goldman JM, Hewitt P, Ward KN,. Chronic anemia due to parvovirus B19 infection in a bone marrow transplant patient after platelet transfusion. Transfusion 1997; 37: 947-52.
12. Zanella A, Rossi F, Cesana C, Foresti A, Nador F, Binda AS, Lunghi G, Cappellini MD, Furione M, Sirchia G,. Transfusion-transmitted human parvovirus B19 infection in a thalassemic patient. Transfusion 1995; 35: 769-72.
13. Yoto Y, Kudoh T, Haseyama K, Suzuki N, Oda T, Katoh T, Takahashi T, Sekiguchi S, Chiba S,. Incidence of human parvovirus B19 DNA detection in blood donors. Br J Haematol 1995; 91: 1017-8.
14. Jordan J, Tiangco B, Kiss J, Koch W,. Human parvovirus B19: prevalence of viral DNA in volunteer blood donors and clinical outcomes of transfusion recipients. Vox Sang 1998; 75: 97-102. (Pubitemid 28490878)
15. Abe R, Shichishima T, Ogawa K, Saitoh Y, Maruyama Y,. Neutropenia due to parvovirus B19 infections in patients with paroxysmal nocturnal hemoglobinuria. Blood transfusion and natural infection cases. Acta Haematol 2006; 116: 245-8. (Pubitemid 44795903)
16. Plentz A, Hahn J, Knöll A, Holler E, Jilg W, Modrow S,. Exposure of hematologic patients to parvovirus B19 as a contaminant of blood cell preparations and blood products. Transfusion 2005; 45: 1811-5. (Pubitemid 43923911)
17. Kleinman SH, Glynn SA, Lee TH, Tobler LH, Schlumpf KS, Todd DS, Qiao H, Yu MY, Busch MP,; National Heart, Lung, and Blood Institute Retrovirus Epidemiology Donor Study-II (NHLBI REDS-II). A linked donor-recipient study to evaluate parvovirus B19 transmission by blood component transfusion. Blood 2009; 114: 3677-83.
18. Yu MY, Alter HJ, Virata-Theimer ML, Geng Y, Ma L, Schechterly CA, Colvin CA, Luban NL,. Parvovirus B19 infection transmitted by transfusion of red blood cells confirmed by molecular analysis of linked donor and recipient samples. Transfusion 2010; 50: 1712-21.
19. Sato H, Takakura F, Kojima E, Fukada K, Okochi K, Maeda Y,. Screening of blood donors for human parvovirus B19. Lancet 1995; 346: 1237-8.
20. Wakamatsu C, Takakura F, Kojima E, Kiriyama Y, Goto N, Matsumoto K, Oyama M, Sato H, Okochi K, Maeda Y,. Screening of blood donors for human parvovirus B19 and characterization of the results. Vox Sang 1999; 76: 14-21. (Pubitemid 29065241)
21. Pharmaceutical and Food Safety Bureau, Blood and Blood Products Division. Ketsuekijigyou houkoku 2008. Tokyo: Japanese Ministry of Health, Labour and Welfare publication; 2009. p. 24-8.
22. Takeda Y, Wakisaka A, Noguchi K, Murozuka T, Katsubayashi Y, Matsumoto S, Tomono T, Nishioka K,. Receptor-mediated haemagglutination screening and reduction in the viral load of parvovirus B19 DNA in immunopurified Factor VIII concentrate (Cross Eight M). Vox Sang 2001; 81: 266-8. (Pubitemid 36806490)
23. Servant A, Laperche S, Lallemand F, Marinho V, De Saint Maur G, Meritet JF, Garbarg-Chenon A,. Genetic diversity within human erythroviruses: identification of three genotypes. J Virol 2002; 76: 9124-34. (Pubitemid 34919871)
24. TRIP National Hemovigilance Office. TRIP annual report 2007. Haag, Netherlands: Transfusion Reactions In Patients Foundation for Hemovigilance; 2009. p. 18-9.
25. Kleinman SH, Glynn SA, Lee TH, Tobler L, Montalvo L, Todd D, Kiss JE, Shyamala V, Busch MP,; National Heart, Lung, Blood Institute Retrovirus Epidemiology Donor Study (REDS-II). Prevalence and quantitation of parvovirus B19 DNA levels in blood donors with a sensitive polymerase chain reaction screening assay. Transfusion 2007; 47: 1756-64. (Pubitemid 47438539)
26. Davenport R, Geohas G, Cohen S, Beach K, Lazo A, Lucchesi K, Pehta J,. Phase IV study of Plas+SD: hepatitis A (HAV) and parvovirus B19 (B19) safety results. Blood 2000; 96: 451a. Abstract 1942.
27. Schmidt M, Themann A, Drexler C, Bayer M, Lanzer G, Menichetti E, Lechner S, Wessin D, Prokoph B, Allain JP, Seifried E, Hourfar MK,. Blood donor screening for parvovirus B19 in Germany and Austria. Transfusion 2007; 47: 1775-82. (Pubitemid 47438562)
28. Schmidt M, Mayr-Wohlfart U, Hourfar MK, Schrezenmeier H, Sireis W, Seifried E,. Infectivity of B19 positive blood products. Vox Sang 2009; 96 (Suppl 1): 54. Abstract 3D-S23-05.
29. Brown KE, Anderson SM, Young NS,. Erythrocyte P antigen: cellular receptor for B19 parvovirus. Science 1993; 262: 114-7. (Pubitemid 23338882)
30. von dem Borne AE, Bos MJ, Joustra-Maas N, Tromp JF, vant Veer MB, van Wijngaarden-du Bois R, Tetteroo PA,. A murine monoclonal IgM antibody specific for blood group P antigen (globoside). Br J Haematol 1986; 63: 35-46. (Pubitemid 16113727)
31. Osaki M, Matsubara K, Iwasaki T, Kurata T, Nigami H, Harigaya H, Baba K,. Severe aplastic anemia associated with human parvovirus B19 infection in a patient without underlying disease. Ann Hematol 1999; 78: 83-6. (Pubitemid 29132439)
32. Groeneveld K, van der Noordaa J,. Blood products and parvovirus B19. Neth J Med 2003; 61: 154-6.
33. Alter HJ,. Pathogen reduction: a precautionary principle paradigm. Transfus Med Rev 2008; 22: 97-102. (Pubitemid 351381952)